Cargando…
Assessment of quality of life in women using Femelis Meno
Over 30% of women suffering from menopausal symptoms use products of plant origin. This paper presents the results of a study devoted to evaluation of the efficacy of the Femelis Meno dietary supplement containing standardized flower pollen and pistil extracts (PI 82-GC FEM).
Autores principales: | Paszkowski, Tomasz, Skrzypulec-Plinta, Violetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107096/ https://www.ncbi.nlm.nih.gov/pubmed/30150915 http://dx.doi.org/10.5114/pm.2018.77306 |
Ejemplares similares
-
Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
por: Bińkowska, Małgorzata, et al.
Publicado: (2022) -
Position statement by Experts of the Polish Menopause and Andropause Society, and the Polish Society of Aesthetic and Reconstructive Gynaecology on the medicinal product Intrarosa(®)
por: Bińkowska, Małgorzata, et al.
Publicado: (2019) -
Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
por: Bińkowska, Małgorzata, et al.
Publicado: (2021) -
Menopausal hormone therapy in questions and answers – a manual for physicians of various specialties
por: Paszkowski, Tomasz, et al.
Publicado: (2019) -
Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2023)